Concepedia

Dario A. Paggiarino

DA

10

Publications

696

Citations

10

H-Index

1984

Active since

Affiliations

Pfizer (United States)(Current)

EyePoint Pharmaceuticals (United States)

Johns Hopkins University

Rabin Medical Center

Quark Pharmaceuticals (United States)

Dario A. Paggiarino is an author at Pfizer (United States) specializing in medicine, ophthalmology, and glaucoma.

ORCID

Top concepts

Publications per year

1984–2024

10

Publications

10

Benzydamine HCl for prophylaxis of radiation-induced oral mucositis

Joel B. Epstein, Sol Silverman, Dario A. Paggiarino et al. · Cancer · 2001 · 268 citations · Full text

Dose-Ranging Evaluation of Intravitreal siRNA PF-04523655 for Diabetic Macular Edema (the DEGAS Study)

Quan Dong Nguyen, Ronald A. Schachar, Chudy I. Nduaka et al. · Investigative Ophthalmology & Visual Science · 2012 · 99 citations

Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Chronic Noninfectious Uveitis Affecting the Posterior Segment

Glenn J. Jaffe, C. Stephen Foster, Carlos Pavésio et al. · Ophthalmology · 2018 · 94 citations

Evaluation of the siRNA PF-04523655 versus Ranibizumab for the Treatment of Neovascular Age-related Macular Degeneration (MONET Study)

Quan Dong Nguyen, Ronald A. Schachar, Chudy I. Nduaka et al. · Ophthalmology · 2012 · 82 citations

, , +5

A phase 2 study of the sphingosine‐1‐phosphate antibody sonepcizumab in patients with metastatic renal cell carcinoma

Sumanta K. Pal, Harry A. Drabkin, James A. Reeves et al. · Cancer · 2016 · 49 citations · Full text

Rows per page

1–5 of 10